Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin infusion rates on cerebral rewarming in CPB
NCT03251599Phase 4Completed
- Sponsor
- Recep Tayyip Erdoğan University
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Nitro G in coronary artery disease (CAD) (2 arms), sponsored by Recep Tayyip Erdoğan University. Primary endpoints: Incidence of Nasopharyngeal temperature > 37 °C and Time to reach 37 °C. Started Aug 2017; status: completed.
02
Drugs
Nitro G
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03251599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251599.